TrialEuropean heart journal2015

Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension.

Raul D Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.